Who owns MoonLake Immunotherapeutics?
Institutional ownership of MLTX from SEC Form 13F filings across 109 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
109
13F holders
$542.0M
value, 2026 filers
35.2%
of shares outstanding (29.6M sh)
29
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of MLTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | D. E. Shaw & Co., Inc. | 3.4M | $65.5M | 0.0% | 4% | +40.8% |
| 2 | Jupiter Topco LLCNEW | 3.1M | $60.1M | 0.0% | 3.7% | new |
| 3 | Weiss Asset Management LP | 2.6M | $50.3M | 0.5% | 3.1% | +51.1% |
| 4 | CITADEL ADVISORS LLC | 2.0M | $38.4M | 0.0% | 2.3% | +49.0% |
| 5 | TWO SIGMA INVESTMENTS, LP | 1.7M | $33.4M | 0.0% | 2% | +52.8% |
| 6 | JPMORGAN CHASE & CO | 1.4M | $27.6M | 0.0% | 1.6% | +27.4% |
| 7 | Point72 Asset Management, L.P. | 1.2M | $22.6M | 0.0% | 1.4% | -15.3% |
| 8 | BlackRock, Inc. | 1.1M | $21.3M | 0.0% | 1.3% | +7.1% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.0M | $20,279 | 0.0% | 1.2% | -19.6% |
| 10 | Balyasny Asset Management L.P. | 912,715 | $17.8M | 0.0% | 1.1% | -14.3% |
| 11 | JANE STREET GROUP, LLC | 853,386 | $16.6M | 0.0% | 1% | +88.1% |
| 12 | Candriam S.C.A. | 769,766 | $15.0M | 0.1% | 0.9% | -5.9% |
| 13 | BANK OF AMERICA CORP /DE/ | 751,897 | $14.6M | 0.0% | 0.9% | +3.7% |
| 14 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 750,777 | $14.6M | 0.0% | 0.9% | +970.4% |
| 15 | HRT FINANCIAL LP | 679,244 | $13,224 | 0.0% | 0.8% | +39.3% |
| 16 | MILLENNIUM MANAGEMENT LLC | 636,187 | $12.4M | 0.0% | 0.8% | +10.4% |
| 17 | MORGAN STANLEY | 563,602 | $11.0M | 0.0% | 0.7% | -8.3% |
| 18 | MARSHALL WACE, LLP | 550,351 | $10.7M | 0.0% | 0.7% | +394.3% |
| 19 | Qube Research & Technologies Ltd | 496,242 | $9.7M | 0.0% | 0.6% | +1056.3% |
| 20 | Verition Fund Management LLCNEW | 414,204 | $8.1M | 0.0% | 0.5% | new |
| 21 | BNP PARIBAS FINANCIAL MARKETS | 341,537 | $6.6M | 0.0% | 0.4% | +42.4% |
| 22 | Jump Financial, LLC | 336,243 | $6.5M | 0.1% | 0.4% | +3.2% |
| 23 | UBS Group AG | 328,522 | $6.4M | 0.0% | 0.4% | +8369.2% |
| 24 | Burkehill Global Management, LPNEW | 250,000 | $4.9M | 0.2% | 0.3% | new |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 247,742 | $4.8M | 0.0% | 0.3% | -27.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.